Delcath Sys Inc (DCTH) financials

NASDAQ · Health Care

$14.04 -4.10% Close Oct 30, 2026 Live

Delcath Sys revenue and earnings by year

Delcath Sys's revenue was $85.2 million in the fiscal year to December 31, 2025, up 129.1% from the year before. Net income was $2.70 million, 3.2% of revenue. Since the fiscal year to December 31, 2017, revenue has grown 53.9% a year on average.

RevenueNet income
-$50.0M$0$50.0M
201720182019202020212022202320242025

Fiscal years, each labelled by the calendar year it ended in.

Income statement, the last 9 fiscal years

In millions of US dollars except per-share figures. Each column is a fiscal year, named by the month it ended.
Fiscal year toDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Revenue85372342233
Revenue growth129.1%1701.7%-24.1%-23.5%116.0%4.2%-53.6%25.5%—
Gross profit73311231122
Gross margin86.2%83.4%69.2%74.8%81.1%61.1%54.5%70.4%74.2%
Operating income1-12-38-34-25-21-20-27-18
Operating margin0.7%-33.4%-1851.9%-1245.1%-690.0%-1294.2%-1260.0%-794.6%-669.1%
Net income3-26-48-37-26-24-9-19-45
Net margin3.2%-70.9%-2308.9%-1342.7%-721.5%-1467.6%-562.0%-564.2%-1661.8%
Diluted EPS$0.07-$0.93-$2.94-$4.12-$3.59-$8.35-$342.83-$504.00-$2275000.00
Free cash flow21-19-31-25-23-24-24-15-16

Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open DCTH in Markets.

How Delcath Sys makes money

Revenue by segment in the quarter to June 30, 2026, as the company reports it.

SegmentRevenueShare
HEPZATOKIT$27.2M93.2%
CHEMOSAT$1.97M6.8%

See also: DCTH returns

No forecast, no recommendation. This page describes Delcath Sys Inc from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.